- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01603966
Low Dose Aspirin Studied With the AggreGuide
July 14, 2012 updated by: Edward R. Teitel, M.D.
Low Dose Aspirin Study With the AggreGuide
This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77099
- Aggredyne, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
community sample
Description
Inclusion Criteria:
- adults
Exclusion Criteria:
- aspirin contraindications
- anticoagulants
- aspirin past week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edward R. Teitel, MD, Aggredyne, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
May 21, 2012
First Submitted That Met QC Criteria
May 22, 2012
First Posted (Estimate)
May 23, 2012
Study Record Updates
Last Update Posted (Estimate)
July 17, 2012
Last Update Submitted That Met QC Criteria
July 14, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Val-030
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Platelet Aggregation
-
Vanderbilt UniversityWithdrawnPlatelet AggregationUnited States
-
Texas Tech University Health Sciences CenterCompletedPlatelet AggregationUnited States
-
Ruhr University of BochumPfizerCompleted
-
Medisch Spectrum TwenteCompletedPlatelet Aggregation | Blood TransfusionNetherlands
-
AstraZenecaCompletedInhibition on Platelet AggregationUnited States
-
Ospedale Santa Croce-Carle CuneoUnknownPlatelet Aggregation Inhibitors
-
University of California, DavisCompletedVascular Function; Platelet AggregationUnited States
-
Aggredyne, Inc.Completed
-
Vanderbilt UniversityTerminatedPlatelet AggregationUnited States
-
National Council of Scientific and Technical Research...Merck Sharp & Dohme LLCCompletedInhibition of Platelet Aggregation by Incretins